September 9, 2024 · STOCK Act disclosure
Representative Josh Gottheimer (Democrat-NJ) sold Halozyme Therapeutics, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on September 9, 2024 and was disclosed on October 3, 2024 (owner: JT). Members of Congress must report such transactions within 45 days under the STOCK Act.